Technical Analysis for CTRV - ContraVir Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade F 0.335 4.69% 0.02
CTRV closed up 4.69 percent on Friday, January 18, 2019, on 18 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CTRV trend table...

Date Alert Name Type % Chg
Jan 18 NR7 Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 20 DMA Support Bullish 4.69%
Jan 17 Spinning Top Other 4.69%
Jan 17 Wide Bands Range Expansion 4.69%
Jan 16 20 DMA Support Bullish 1.52%
Jan 16 Wide Bands Range Expansion 1.52%
Jan 15 Wide Bands Range Expansion 1.52%
Jan 15 Upper Bollinger Band Touch Strength 1.52%
Jan 14 Wide Bands Range Expansion -1.47%

Older signals for CTRV ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the discovery and development of targeted antiviral therapies. Its lead candidate, FV-100, is an orally available nucleoside analogue prodrug that is being developed for the treatment of herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus. The company has completed Phase I trials of FV-100 in volunteers, as well as a Phase IIa clinical trial in shingles patients. It also plans to conduct a trial in patients with shingles to further explore FV-100's potential to treat the long-lasting nerve pain typically associated with shingles. The company was founded in 2013 and is headquartered in Edison, New Jersey. ContraVir Pharmaceuticals, Inc. is a former subsidiary of Synergy Pharmaceuticals, Inc.
Is CTRV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.96
52 Week Low 0.213
Average Volume 173,113
200-Day Moving Average 1.0047
50-Day Moving Average 0.4183
20-Day Moving Average 0.3181
10-Day Moving Average 0.3385
Average True Range 0.059
ADX 17.09
+DI 17.6806
-DI 15.8749
Chandelier Exit (Long, 3 ATRs ) 0.243
Chandelier Exit (Short, 3 ATRs ) 0.39
Upper Bollinger Band 0.3708
Lower Bollinger Band 0.2654
Percent B (%b) 0.66
BandWidth 33.134235
MACD Line -0.0212
MACD Signal Line -0.0291
MACD Histogram 0.008
Fundamentals Value
Market Cap 26.13 Million
Num Shares 78 Million
EPS -0.30
Price-to-Earnings (P/E) Ratio -1.11
Price-to-Sales 0.00
Price-to-Book 5.28
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.39
Resistance 3 (R3) 0.39 0.38 0.38
Resistance 2 (R2) 0.38 0.36 0.38 0.38
Resistance 1 (R1) 0.36 0.35 0.35 0.35 0.38
Pivot Point 0.34 0.34 0.33 0.34 0.34
Support 1 (S1) 0.32 0.32 0.31 0.32 0.29
Support 2 (S2) 0.30 0.31 0.30 0.29
Support 3 (S3) 0.28 0.30 0.29
Support 4 (S4) 0.28